AI Hype Cycle: Implementing AI in Biopharma Marketing Strategies
Wednesday, 18 September 2024, 03:00
AI Hype Cycle: A New Era in Biopharma Marketing
Artificial Intelligence has transformed from a futuristic concept to a critical component in biopharma marketing. Companies like Bayer and Daiichi Sankyo are at the forefront of this change, exploring AI's potential while navigating the complex landscape of healthcare communications.
Insights from Industry Leaders
- Bayer's Perspective: Focusing on targeted consumer engagement strategies.
- Daiichi Sankyo's Innovations: Implementing data analytics for better market reach.
Challenges in AI Adoption
While AI presents exciting opportunities, there are challenges:
- Lack of trust in automated decisions.
- Regulatory hurdles affecting adoption.
- The need for quality data to feed AI technologies.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.